Henry Chijcheapaza-Flores
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Henry Chijcheapaza-Flores has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Romain Nicot
Univ. Lille, CHU Lille, INSERM, Department of Oral and Maxillofacial Surgery, U1365 - Advanced Drug Delivery Systems
4 shared publications Feng Chai
INSERM, CHU Lille, U1008 - Controlled Drug Delivery Systems and Biomaterials, University of Lille, Lille, France
3 shared publications- Maria José Garcia-Fernandez
Univ. Lille, INSERM, CHU Lille, U1008—Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France
3 shared publications Nicolas Blanchemain
INSERM, CHU Lille, U1008 - Controlled Drug Delivery Systems and Biomaterials, University of Lille, Lille, France
3 shared publications- Nicolas Blanchemain
Univ. Lille, INSERM, CHU Lille, U1008-Advanced Drug Delivery Systems and Biomaterials, F-59000 Lille, France
3 shared publications - Bernard Martel
Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207—UMET—Unité Matériaux et Transformations, F-59000 Lille, France
2 shared publications
Latest Publications
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Development of an antiinflammatory viscosupplementation hydrogel based on chitosan and polymer of cyclodextrin for the treatment of osteoarticular diseases
Développement d’un hydrogel de viscosupplémentation et antiinflammatoire à base de chitosan et un polymère de cyclodextrine pour le traitement des maladies ostéoarticulaires: Les maladies ostéo-articulaires sont des maladies du système musculo-squelettique. La maladie est répandue chez les athlètes, les personnes souffrant de blessures ou de traumatismes articulaires et chez les personnes âgées. Les troubles de l'articulation temporo-mandibulaire (ATM) sont un groupe de maladies ostéo-articulaires qui touchent 30 % de la population adulte et 11 % des enfants et des adolescents. Le traitement principal des troubles de l'ATM implique des injections intra-articulaires de viscosuppléments (solutions d'hyaluronate de sodium à 1%), qui ont une activité lubrifiante, et l'administration orale d'anti-inflammatoires non stéroïdiens (AINS). Cependant, ce traitement est souvent insuffisant en raison de la faible efficacité des viscosuppléments et des effets secondaires de l'utilisation à long terme d'AINS, notamment les lésions rénales, les ulcères gastriques et l'hypertension. L'objectif de ce travail de thèse était de développer un traitement innovant par viscosupplémentation utilisant un hydrogel à base de chitosane et un polymère de cyclodextrine pour la libération intra-articulaire d'un agent anti-inflammatoire.Le chitosane (CHT) est un polysaccharide obtenu par désacétylation de la chitine, qui est obtenue à partir de la coquille des crustacés. D'autre part, les cyclodextrines (CD) sont des excipients pharmaceutiques largement utilisés en raison de leur capacité à former des complexes d'inclusion avec des médicaments et à prolonger leur libération. Le PCD utilisé dans cette étude a été produit dans le laboratoire de l'Unité de Matériaux et Transformation (UMET) et comprennent deux fractions : une fraction soluble (PCDs) et une fraction insoluble (PCDi), les deux fractions ont été utilisées dans ce travail. Le CHT et PCD ont la capacité de former des complexes polyélectrolytiques (PEC) en raison des groupes aminés présents dans le CHT et des groupes carboxylates présents dans le PCD. Initialement, ce projet s'est concentré sur l'évaluation de diverses formulations de CHT/PCDs/PCDi afin d'évaluer leurs propriétés viscoélastiques et leur activité lubrifiante, qui sont essentielles pour le développement d'un hydrogel injectable pour la viscosupplémentation. Par la suite, le projet visait à développer une formulation contenant un anti-inflammatoire non stéroïdien (AINS), des formulations CHT/PCDs/PCDi/NaNX, et à évaluer la cinétique de libération du médicament. Ensuite, le projet visait à stériliser les poudres d'hydrogels et à effectuer un test in vivo des formulations CHT/PCDs/PCDi et CHT/PCDs/PCDi/NaNX. Enfin, une étude prospective a été menée pour combiner les propriétés de la formulation de base CHT/PCDs/PCDi avec les propriétés antioxydantes d'un conjugué chitosane :acide rosmarinique (CHT :RA). Les résultats du chapitre de cette recherche ont permis le développement d'une formulation d'hydrogel CHT/PCDs/PCDi. Les caractéristiques viscoélastiques ont démontré que l'hydrogel était un solide avec des propriétés viscoélastiques, qui présentait un comportement rhéofluidifiant par cisaillement et autoréparant après une forte contrainte. De plus, l'action lubrifiante a été confirmée à l'aide d'un tribo-rhéomètre à broche sur disque. Deuxièmement, une étude a été menée pour incorporer du naproxène sodique (NaNX), un AINS, dans l'hydrogel. Les résultats ont révélé la formation d'un hydrogel par granulation humide de PCD et de NaNX. De plus, l'étude a confirmé la formation d'un complexe d'inclusion et la libération prolongée de NaNX à partir de la matrice d'hydrogel. Par la suite, l'oxyde d'éthylène (EtO) et les rayons gamma ont été utilisés pour stériliser les poudres CHT et PCDs/PCDi et PCDs/PCDi/NaNX, respectivement
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Development of an antiinflammatory viscosupplementation hydrogel based on chitosan and polymer of cyclodextrin for the treatment of osteoarticular diseases
Développement d’un hydrogel de viscosupplémentation et antiinflammatoire à base de chitosan et un polymère de cyclodextrine pour le traitement des maladies ostéoarticulaires: Les maladies ostéo-articulaires sont des maladies du système musculo-squelettique. La maladie est répandue chez les athlètes, les personnes souffrant de blessures ou de traumatismes articulaires et chez les personnes âgées. Les troubles de l'articulation temporo-mandibulaire (ATM) sont un groupe de maladies ostéo-articulaires qui touchent 30 % de la population adulte et 11 % des enfants et des adolescents. Le traitement principal des troubles de l'ATM implique des injections intra-articulaires de viscosuppléments (solutions d'hyaluronate de sodium à 1%), qui ont une activité lubrifiante, et l'administration orale d'anti-inflammatoires non stéroïdiens (AINS). Cependant, ce traitement est souvent insuffisant en raison de la faible efficacité des viscosuppléments et des effets secondaires de l'utilisation à long terme d'AINS, notamment les lésions rénales, les ulcères gastriques et l'hypertension. L'objectif de ce travail de thèse était de développer un traitement innovant par viscosupplémentation utilisant un hydrogel à base de chitosane et un polymère de cyclodextrine pour la libération intra-articulaire d'un agent anti-inflammatoire.Le chitosane (CHT) est un polysaccharide obtenu par désacétylation de la chitine, qui est obtenue à partir de la coquille des crustacés. D'autre part, les cyclodextrines (CD) sont des excipients pharmaceutiques largement utilisés en raison de leur capacité à former des complexes d'inclusion avec des médicaments et à prolonger leur libération. Le PCD utilisé dans cette étude a été produit dans le laboratoire de l'Unité de Matériaux et Transformation (UMET) et comprennent deux fractions : une fraction soluble (PCDs) et une fraction insoluble (PCDi), les deux fractions ont été utilisées dans ce travail. Le CHT et PCD ont la capacité de former des complexes polyélectrolytiques (PEC) en raison des groupes aminés présents dans le CHT et des groupes carboxylates présents dans le PCD. Initialement, ce projet s'est concentré sur l'évaluation de diverses formulations de CHT/PCDs/PCDi afin d'évaluer leurs propriétés viscoélastiques et leur activité lubrifiante, qui sont essentielles pour le développement d'un hydrogel injectable pour la viscosupplémentation. Par la suite, le projet visait à développer une formulation contenant un anti-inflammatoire non stéroïdien (AINS), des formulations CHT/PCDs/PCDi/NaNX, et à évaluer la cinétique de libération du médicament. Ensuite, le projet visait à stériliser les poudres d'hydrogels et à effectuer un test in vivo des formulations CHT/PCDs/PCDi et CHT/PCDs/PCDi/NaNX. Enfin, une étude prospective a été menée pour combiner les propriétés de la formulation de base CHT/PCDs/PCDi avec les propriétés antioxydantes d'un conjugué chitosane :acide rosmarinique (CHT :RA). Les résultats du chapitre de cette recherche ont permis le développement d'une formulation d'hydrogel CHT/PCDs/PCDi. Les caractéristiques viscoélastiques ont démontré que l'hydrogel était un solide avec des propriétés viscoélastiques, qui présentait un comportement rhéofluidifiant par cisaillement et autoréparant après une forte contrainte. De plus, l'action lubrifiante a été confirmée à l'aide d'un tribo-rhéomètre à broche sur disque. Deuxièmement, une étude a été menée pour incorporer du naproxène sodique (NaNX), un AINS, dans l'hydrogel. Les résultats ont révélé la formation d'un hydrogel par granulation humide de PCD et de NaNX. De plus, l'étude a confirmé la formation d'un complexe d'inclusion et la libération prolongée de NaNX à partir de la matrice d'hydrogel. Par la suite, l'oxyde d'éthylène (EtO) et les rayons gamma ont été utilisés pour stériliser les poudres CHT et PCDs/PCDi et PCDs/PCDi/NaNX, respectivement
- Open Access
Efficacy of Intra-Articular Injection of Botulinum Toxin Type A (IncobotulinumtoxinA) in Temporomandibular Joint Osteoarthritis: A Three-Arm Controlled Trial in Rats
Temporomandibular disorders (TMD) are complex pathologies responsible for chronic orofacial pain. Intramuscular injection of botulinum toxin A (BoNT/A) has shown effectiveness in knee and shoulder osteoarthritis, as well as in some TMDs such as masticatory myofascial pain, but its use remains controversial. This study aimed to evaluate the effect of intra-articular BoNT/A injection in an animal model of temporomandibular joint osteoarthritis. A rat model of temporomandibular osteoarthritis was used to compare the effects of intra-articular injection of BoNT/A, placebo (saline), and hyaluronic acid (HA). Efficacy was compared by pain assessment (head withdrawal test), histological analysis, and imaging performed in each group at different time points until day 30. Compared with the rats receiving placebo, those receiving intra-articular BoNT/A and HA had a significant decrease in pain at day 14. The analgesic effect of BoNT/A was evident as early as day 7, and lasted until day 21. Histological and radiographic analyses showed decrease in joint inflammation in the BoNT/A and HA groups. The osteoarthritis histological score at day 30 was significantly lower in the BoNT/A group than in the other two groups (p = 0.016). Intra-articular injection of BoNT/A appeared to reduce pain and inflammation in experimentally induced temporomandibular osteoarthritis in rats.
Open AccessEfficacy of Intra-Articular Injection of Botulinum Toxin Type A (IncobotulinumtoxinA) in Temporomandibular Joint Osteoarthritis: A Three-Arm Controlled Trial in Rats
Temporomandibular disorders (TMD) are complex pathologies responsible for chronic orofacial pain. Intramuscular injection of botulinum toxin A (BoNT/A) has shown effectiveness in knee and shoulder osteoarthritis, as well as in some TMDs such as masticatory myofascial pain, but its use remains controversial. This study aimed to evaluate the effect of intra-articular BoNT/A injection in an animal model of temporomandibular joint osteoarthritis. A rat model of temporomandibular osteoarthritis was used to compare the effects of intra-articular injection of BoNT/A, placebo (saline), and hyaluronic acid (HA). Efficacy was compared by pain assessment (head withdrawal test), histological analysis, and imaging performed in each group at different time points until day 30. Compared with the rats receiving placebo, those receiving intra-articular BoNT/A and HA had a significant decrease in pain at day 14. The analgesic effect of BoNT/A was evident as early as day 7, and lasted until day 21. Histological and radiographic analyses showed decrease in joint inflammation in the BoNT/A and HA groups. The osteoarthritis histological score at day 30 was significantly lower in the BoNT/A group than in the other two groups (p = 0.016). Intra-articular injection of BoNT/A appeared to reduce pain and inflammation in experimentally induced temporomandibular osteoarthritis in rats.
- Open Access
Injectable Chitosan-Based Hydrogels for Trans-Cinnamaldehyde Delivery in the Treatment of Diabetic Foot Ulcer Infections
Diabetic foot ulcers (DFU) are among the most common complications in diabetic patients and affect 6.8% of people worldwide. Challenges in the management of this disease are decreased blood diffusion, sclerotic tissues, infection, and antibiotic resistance. Hydrogels are now being used as a new treatment option since they can be used for drug delivery and to improve wound healing. This project aims to combine the properties of hydrogels based on chitosan (CHT) and the polymer of β cyclodextrin (PCD) for local delivery of cinnamaldehyde (CN) in diabetic foot ulcers. This work consisted of the development and characterisation of the hydrogel, the evaluation of the CN release kinetics and cell viability (on a MC3T3 pre-osteoblast cell line), and the evaluation of the antimicrobial and antibiofilm activity (S. aureus and P. aeruginosa). The results demonstrated the successful development of a cytocompatible (ISO 10993-5) injectable hydrogel with antibacterial (99.99% bacterial reduction) and antibiofilm activity. Furthermore, a partial active molecule release and an increase in hydrogel elasticity were observed in the presence of CN. This leads us to hypothesise that a reaction between CHT and CN (a Schiff base) can occur and that CN could act as a physical crosslinker, thus improving the viscoelastic properties of the hydrogel and limiting CN release.
Open AccessInjectable Chitosan-Based Hydrogels for Trans-Cinnamaldehyde Delivery in the Treatment of Diabetic Foot Ulcer Infections
Diabetic foot ulcers (DFU) are among the most common complications in diabetic patients and affect 6.8% of people worldwide. Challenges in the management of this disease are decreased blood diffusion, sclerotic tissues, infection, and antibiotic resistance. Hydrogels are now being used as a new treatment option since they can be used for drug delivery and to improve wound healing. This project aims to combine the properties of hydrogels based on chitosan (CHT) and the polymer of β cyclodextrin (PCD) for local delivery of cinnamaldehyde (CN) in diabetic foot ulcers. This work consisted of the development and characterisation of the hydrogel, the evaluation of the CN release kinetics and cell viability (on a MC3T3 pre-osteoblast cell line), and the evaluation of the antimicrobial and antibiofilm activity (S. aureus and P. aeruginosa). The results demonstrated the successful development of a cytocompatible (ISO 10993-5) injectable hydrogel with antibacterial (99.99% bacterial reduction) and antibiofilm activity. Furthermore, a partial active molecule release and an increase in hydrogel elasticity were observed in the presence of CN. This leads us to hypothesise that a reaction between CHT and CN (a Schiff base) can occur and that CN could act as a physical crosslinker, thus improving the viscoelastic properties of the hydrogel and limiting CN release.
- Open Access
- 31 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0281135
Comparison of chemical-induced temporomandibular osteoarthritis rat models (monosodium iodoacetate versus collagenase type II) for the study of prolonged drug delivery systems
To compare two agents that can induce a rat model of temporomandibular joint osteoarthritis (TMJOA) by chemical induction: monosodium iodoacetate (MIA) and collagenase type 2 (Col-2). We wished to ascertain the best agent for assessing drug-delivery systems (DDSs). Male Wistar rats underwent intra-articular injection with MIA or Col-2. They were manipulated for 30 days. The head withdrawal threshold (HWT), immunohistological assessment, and positron emission tomography (PET) were used to evaluate the relevance of our models. For both the MIA and Col-2 groups, pain persisted for 30 days after injection. Change in the HWT showed that Col-2 elicited a strong action initially that decreased progressively. MIA had a constant action upon pain behavior. Histology of TMJ tissue from both groups showed progressive degradation of TMJ components. MIA and Col-2 induced orofacial pain by their local chemical action on TMJs. However, based on a prolonged and greater sustained effect on the pain threshold, persistent histological changes, and imaging results, MIA appeared to be more suitable for creation of a rat model of TMJOA for the study of DDSs.
- 31 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0281135
Open AccessComparison of chemical-induced temporomandibular osteoarthritis rat models (monosodium iodoacetate versus collagenase type II) for the study of prolonged drug delivery systems
To compare two agents that can induce a rat model of temporomandibular joint osteoarthritis (TMJOA) by chemical induction: monosodium iodoacetate (MIA) and collagenase type 2 (Col-2). We wished to ascertain the best agent for assessing drug-delivery systems (DDSs). Male Wistar rats underwent intra-articular injection with MIA or Col-2. They were manipulated for 30 days. The head withdrawal threshold (HWT), immunohistological assessment, and positron emission tomography (PET) were used to evaluate the relevance of our models. For both the MIA and Col-2 groups, pain persisted for 30 days after injection. Change in the HWT showed that Col-2 elicited a strong action initially that decreased progressively. MIA had a constant action upon pain behavior. Histology of TMJ tissue from both groups showed progressive degradation of TMJ components. MIA and Col-2 induced orofacial pain by their local chemical action on TMJs. However, based on a prolonged and greater sustained effect on the pain threshold, persistent histological changes, and imaging results, MIA appeared to be more suitable for creation of a rat model of TMJOA for the study of DDSs.
- 1 October 2022
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 123 (5) , e336-e341
Systematic review of studies on drug-delivery systems for management of temporomandibular-joint osteoarthritis
- 1 October 2022
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 123 (5) , e336-e341
Systematic review of studies on drug-delivery systems for management of temporomandibular-joint osteoarthritis
- Open Access
- 5 November 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (11) , 1352
How Adding Chlorhexidine or Metallic Nanoparticles Affects the Antimicrobial Performance of Calcium Hydroxide Paste as an Intracanal Medication: An In Vitro Study
The aim of our study was to explore the potential value of metallic (Ag, Cu, and Zn) salts, polymer/metallic nanoparticles, and chlorhexidine (CHX) for improving the antimicrobial activity of calcium hydroxide (CH) against E. faecalis and C. albicans, associated with persistent endodontic infections. A first screening was performed by determining minimum inhibitory/bactericidal concentrations (MIC/MBC). Antimicrobial activity of the CH paste mixed with metallic salts, chitosan or cyclodextrin polymer metallic nanoparticles was compared to the antimicrobial activity of CH paste alone and CH + CHX using a time-kill kinetics assay. The effect of the antimicrobials on the rheological and the key mechanical properties were also examined. Copper and zinc were discarded because of their MIC/MBC values and silver because of its kill time curve profile. Except for a slower setting time after 24 h and a higher weight loss after 1 week of incubation, the mechanical behavior of the CH paste was unaffected by the addition of CHX. Polymeric/metallic nanoparticles failed to potentiate the antimicrobial effect of CH. By contrast, CHX increased this effect and thus could help eradicate E. faecalis associated with persistent root canal infections without altering the desired key physical properties of the CH paste.
- 5 November 2021
- Published by MDPI AG in Antibiotics
- Vol. 10 (11) , 1352
Open AccessHow Adding Chlorhexidine or Metallic Nanoparticles Affects the Antimicrobial Performance of Calcium Hydroxide Paste as an Intracanal Medication: An In Vitro Study
The aim of our study was to explore the potential value of metallic (Ag, Cu, and Zn) salts, polymer/metallic nanoparticles, and chlorhexidine (CHX) for improving the antimicrobial activity of calcium hydroxide (CH) against E. faecalis and C. albicans, associated with persistent endodontic infections. A first screening was performed by determining minimum inhibitory/bactericidal concentrations (MIC/MBC). Antimicrobial activity of the CH paste mixed with metallic salts, chitosan or cyclodextrin polymer metallic nanoparticles was compared to the antimicrobial activity of CH paste alone and CH + CHX using a time-kill kinetics assay. The effect of the antimicrobials on the rheological and the key mechanical properties were also examined. Copper and zinc were discarded because of their MIC/MBC values and silver because of its kill time curve profile. Except for a slower setting time after 24 h and a higher weight loss after 1 week of incubation, the mechanical behavior of the CH paste was unaffected by the addition of CHX. Polymeric/metallic nanoparticles failed to potentiate the antimicrobial effect of CH. By contrast, CHX increased this effect and thus could help eradicate E. faecalis associated with persistent root canal infections without altering the desired key physical properties of the CH paste.
- 1 August 2021
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 79 (8) , 1650-1671
A Systematic Review of Rat Models With Temporomandibular Osteoarthritis Suitable for the Study of Emerging Prolonged Intra-Articular Drug Delivery Systems
- 1 August 2021
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 79 (8) , 1650-1671
A Systematic Review of Rat Models With Temporomandibular Osteoarthritis Suitable for the Study of Emerging Prolonged Intra-Articular Drug Delivery Systems